Document Detail

The radiosurgical treatment of arteriovenous malformations: obliteration, morbidities, and performance status.
MedLine Citation:
PMID:  20400239     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: This study examined the single-center treatment outcomes of arteriovenous malformations (AVMs) of the brain using stereotactic radiosurgery, with regard to obliteration, predictive factors, morbidities, and patient performance status.
PATIENTS AND METHODS: 127 patients were treated between 1990 and 2008 by use of linear accelerator or Gamma Knife. Their median age was 37 years, the median AVM volume was 7.3 cc (range, 0.014-113.13 cc), and the median follow-up duration was 42 months (range, 6-209 months). Forty-two percent of patients presented with intracranial hemorrhage, 31% received embolization, and 8% underwent prior resection. Thirty-one percent of patients received more than one round of radiosurgery.
RESULTS: 64% of patients had complete obliteration confirmed by magnetic resonance imaging or angiography. Positive predictors of obliteration included pretreatment hemorrhage (p = 0.042), smaller AVM volume (odds ratio = 1.25; 95% CI, 1.03-1.52), and larger marginal dose (odds ratio = 0.292; 95% CI, 0.100-0.820), whereas embolization (p < 0.001) was a negative predictor . The annual risk of hemorrhage after radiosurgery was 2.2%, and the risk of death as a result of hemorrhage was 0.6-1.3%. Eleven percent of patients reported new or worsened neurologic symptoms. Radiosurgery was effective in treating AVM-related headaches (p < 0.001) but did not improve the performance status of patients.
CONCLUSIONS: Stereotactic radiosurgery is an effective tool in the treatment of AVMs and amelioration of AVM-related headaches, but it did not affect the patients' performance status. Factors affecting obliteration include prior hemorrhage, marginal dose, prior embolization, and AVM volume. Risk of hemorrhage persists in the latency period after radiosurgery, and it remains finite even after complete obliteration.
Daniel Q Sun; Kathryn A Carson; Shaan M Raza; Sachin Batra; Lawrence R Kleinberg; Michael Lim; Judy Huang; Daniele Rigamonti
Related Documents :
21049209 - Outpatient percutaneous treatment of deep venous malformations using pure ethanol at lo...
20948399 - Spontaneous intracerebral hemorrhage with ventricular extension and the grading of obst...
20065879 - A comparative study of the patients with bilateral or unilateral chronic subdural hemat...
7942199 - Radiosurgery with the first austrian cobalt-60 gamma-unit. a one year experience.
23378279 - New approach to direct stenting using a novel 'all-in-one' coronary stent system via 5 ...
18671629 - Clinical and neuroimaging outcome of cerebral arteriovenous malformations after gamma k...
7041759 - Splenic and total-body irradiation treatment of myasthenia gravis.
23466929 - The sorin freedom solo stentless tissue valve: early outcomes after aortic valve replac...
19855269 - High-sensitivity c-reactive protein and plaque composition in patients with stable angi...
Publication Detail:
Type:  Journal Article     Date:  2010-04-17
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  80     ISSN:  1879-355X     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  354-61     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, MD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer pat...
Next Document:  Red Shell: Defining a High-risk Zone of Normal Tissue Damage in Stereotactic Body Radiation Therapy.